ShockWave Medical

General Information

We are a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. We aim to establish a new standard of care for medical device treatment of atherosclerotic cardiovascular disease through our differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which we refer to as intravascular lithotripsy (“IVL”). Our IVL system (our “IVL System”), which leverages our IVL technology (our “IVL Technology”), is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes.

Employees: 162
Founded: 2009
Contact Information
Address 5403 Betsy Ross Drive, Santa Clara, CA 95054, US
Phone Number (510) 279-4262
Web Address
View Prospectus: ShockWave Medical
Financial Information
Market Cap $457.4mil
Revenues $12.26 mil (last 12 months)
Net Income $-41.1 mil (last 12 months)
IPO Profile
Symbol SWAV
Exchange NASDAQ
Shares (millions): 5.7
Price range $17.00 - $17.00
Est. $ Volume $96.9 mil
Manager / Joint Managers Morgan Stanley/ BofA Securities
CO-Managers Wells Fargo Securities/ Canaccord Genuity
Expected To Trade: 3/7/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change